The synthetic tissue structures simulate several kinds of cells found in the human heart. Researchers can check in on their ...
in patients who failed therapy with drugs targeting vascular endothelial growth factor (VEGF). Sodhi and his colleagues ...
A study conducted at the Center for Research on Redox Processes in Biomedicine (Redoxoma) helps understand how high blood ...
The ability of the bone marrow to produce healthy blood cells declines significantly with age, leading to age-related ...
The study demonstrates that activating the vitamin D receptor (VDR) with calcitriol suppresses cell proliferation in ...
Chronic kidney disease (CKD) affects millions worldwide, and as the demand for effective dialysis treatments grows, ...
AlloVir has entered into a definitive agreement for the acquisition of the complete outstanding shares of Kalaris ...
An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...
Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...
In addition to its lead GeneTAC™ small molecule, DT-216, in development for patients with Friedreich ataxia, the company is advancing programs in Fuchs endothelial corneal dystrophy, Huntington’s ...